Last updated on August 2018

Study of E6011 in Japanese Subjects With Primary Biliary Cholangitis Inadequately Responding to Ursodeoxycholic Acid


Brief description of study

This study is a placebo-controlled, randomized, double-blind, multicenter, parallel-group comparison study in primary biliary cholangitis participants inadequately responding to ursodeoxycholic acid.

Clinical Study Identifier: NCT03092765

Contact Investigators or Research Sites near you

Start Over

Public Relations Group

EA Pharma trial site #1
Sapporo, Japan
  Connect »

Public Relations Group

EA Pharma trial site #2
Sapporo, Japan
  Connect »